Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Gross Profit (2016 - 2025)

Historic Gross Profit for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to $93.1 million.

  • CorMedix's Gross Profit rose 76429.76% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.5 million, marking a year-over-year increase of 183133.16%. This contributed to the annual value of $40.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Gross Profit of $93.1 million as of Q3 2025, which was up 76429.76% from $37.9 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Gross Profit peaked at $93.1 million during Q3 2025, and registered a low of -$818539.0 during Q1 2024.
  • Moreover, its 4-year median value for Gross Profit was $26922.0 (2021), whereas its average is $13.9 million.
  • As far as peak fluctuations go, CorMedix's Gross Profit plummeted by 12747.17% in 2021, and later surged by 1268329.35% in 2025.
  • Over the past 4 years, CorMedix's Gross Profit (Quarter) stood at $8390.0 in 2021, then soared by 249.18% to $29296.0 in 2022, then surged by 102420.4% to $30.0 million in 2024, then soared by 209.91% to $93.1 million in 2025.
  • Its Gross Profit was $93.1 million in Q3 2025, compared to $37.9 million in Q2 2025 and $37.5 million in Q1 2025.